The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....